Compounds and methods for kinase modulation, and indications therefor
    19.
    发明授权
    Compounds and methods for kinase modulation, and indications therefor 有权
    用于激酶调节的化合物和方法及其适应症

    公开(公告)号:US08198273B2

    公开(公告)日:2012-06-12

    申请号:US12773798

    申请日:2010-05-04

    CPC分类号: C07D471/04

    摘要: Compounds and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, and forms thereof are active on each of BRaf and c-Raf-1 protein kinase, and may also be active on either or both of A-Raf and B-Raf V600E protein kinase. Also described are methods of use thereof to treat diseases and conditions, including melanoma, colorectal cancer, thyroid cancer, ovarian cancer, and biliary tract cancer.

    摘要翻译: 其化合物及其盐,其制剂,其缀合物,其衍生物,其形式及用途。 在某些方面和实施方案中,所描述的化合物或其盐,其制剂,其缀合物,其衍生物及其形式在BRaf和c-Raf-1蛋白激酶中的每一个上都是有活性的,并且还可以在 A-Raf和B-Raf V600E蛋白激酶。 还描述了其用于治疗疾病和病症的方法,包括黑素瘤,结肠直肠癌,甲状腺癌,卵巢癌和胆道癌。

    COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
    20.
    发明申请
    COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR 审中-公开
    化合物及其调节方法及其适应症

    公开(公告)号:US20120245174A1

    公开(公告)日:2012-09-27

    申请号:US13491480

    申请日:2012-06-07

    CPC分类号: C07D471/04

    摘要: Compounds and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, and forms thereof are active on each of BRaf and c-Raf-1 protein kinase, and may also be active on either or both of A-Raf and B-Raf V600E protein kinase. Also described are methods of use thereof to treat diseases and conditions, including melanoma, colorectal cancer, thyroid cancer, ovarian cancer, and biliary tract cancer.

    摘要翻译: 其化合物及其盐,其制剂,其缀合物,其衍生物,其形式及用途。 在某些方面和实施方案中,所描述的化合物或其盐,其制剂,其缀合物,其衍生物及其形式在BRaf和c-Raf-1蛋白激酶中的每一个上都是有活性的,并且还可以在 A-Raf和B-Raf V600E蛋白激酶。 还描述了其用于治疗疾病和病症的方法,包括黑素瘤,结肠直肠癌,甲状腺癌,卵巢癌和胆道癌。